{
  "id": 211,
  "text": "The European Gyn GEC ESTRO group has become the major driving force in this development, providing essential recommendations to guide this treatment as early as 2005 and 2006.This group also started large multi-center retrospective and prospective clinical trials and evaluations of image guided adaptive brachytherapy (RetroEMBRACE, EMBRACE I (2008-2015) and EMBRACE II (since 2016)) benchmarking these innovations in a multicentre clinical setting13.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The European Gyn GEC ESTRO group has become the major driving force in this development, providing essential recommendations to guide this treatment as early as 2005 and 2006.This group also started large multi-center retrospective and prospective clinical trials and evaluations of image guided adaptive brachytherapy (RetroEMBRACE, EMBRACE I (2008-2015) and EMBRACE II (since 2016)) benchmarking th\n\n<question>: ",
  "ChatGPT_response_0": "这个发展的主要动力来自于欧洲Gyn GEC ESTRO小组，他们提供了至关重要的建议，引导了这一治疗的发展。此外，该小组还开展了大型多中心的回顾性和前瞻性临床试验和评估，对图像引导自适应放射治疗进行了基准测试。",
  "query": "这个发展的主要动力来自于哪个组织？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 这个发展的主要动力来自于哪个组织？\n\n<reference text>: The European Gyn GEC ESTRO group has become the major driving force in this development, providing essential recommendations to guide this treatment as early as 2005 and 2006.This group also started large multi-center retrospective and prospective clinical trials and evaluations of image guided adaptive brachytherapy (RetroEMBRACE, EMBRACE I (2008-2015) and EMBRACE II (since 2016)) benchmarking these innovations in a multicentre clinical setting13.\n\n<reply>: ",
  "response": "这个发展的主要动力来自于欧洲Gyn GEC ESTRO小组，他们提供了至关重要的建议，引导了这一治疗的发展。此外，该小组还开展了大型多中心的回顾性和前瞻性临床试验和评估，对图像引导自适应放射治疗进行了基准测试。"
}